{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:59:43Z","timestamp":1791662383596,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02083-0","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:03:54Z","timestamp":1778072634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Artificial intelligence in ovarian pathophysiology and management: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7121-6152","authenticated-orcid":false,"given":"Hang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7862-6159","authenticated-orcid":false,"given":"Lifan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"3","key":"2083_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3892\/or.2024.8705","volume":"51","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lin W, Zhuang X, et al. Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review). Oncol Rep. 2024;51(3):46.","journal-title":"Oncol Rep"},{"issue":"7","key":"2083_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s11864-025-01331-7","volume":"26","author":"RU K","year":"2025","unstructured":"K RU, Elango AP, Subramanian R, Ks S. The Evolving Landscape of Ovarian Cancer: Innovations in Biotechnology and Artificial Intelligence- Based Screening and Treatment. Curr Treat Options Oncol. 2025;26(7):622\u201337.","journal-title":"Curr Treat Options Oncol"},{"key":"2083_CR3","doi-asserted-by":"publisher","first-page":"1106625","DOI":"10.3389\/fendo.2023.1106625","volume":"14","author":"FJ Barrera","year":"2023","unstructured":"Barrera FJ, Brown EDL, Rojo A, et al. Application of machine learning and artificial intelligence in the diagnosis and classification of polycystic ovarian syndrome: a systematic review. Front Endocrinol (Lausanne). 2023;14:1106625.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2083_CR4","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11547-025-02032-9","volume":"130","author":"J Wang","year":"2025","unstructured":"Wang J, Chen R, Long H, et al. Artificial intelligence in polycystic ovarian syndrome management: past, present, and future. Radiol Med. 2025;130(9):1409\u201341.","journal-title":"Radiol Med"},{"issue":"3","key":"2083_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.24920\/003963","volume":"36","author":"X Chen","year":"2021","unstructured":"Chen X, Huo XF, Wu Z, Lu JJ. Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers. Chin Med Sci J. 2021;36(3):196\u2013203.","journal-title":"Chin Med Sci J"},{"issue":"2","key":"2083_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/CBM-210301","volume":"33","author":"D Mikdadi","year":"2022","unstructured":"Mikdadi D, O\u2019Connell KA, Meacham PJ, et al. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery. Cancer Biomark. 2022;33(2):173\u201384.","journal-title":"Cancer Biomark"},{"issue":"2","key":"2083_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.rbmo.2021.10.006","volume":"44","author":"G Letterie","year":"2022","unstructured":"Letterie G, MacDonald A, Shi Z. An artificial intelligence platform to optimize workflow during ovarian stimulation and IVF: process improvement and outcome-based predictions. Reprod Biomed Online. 2022;44(2):254\u201360.","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"2083_CR8","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1007\/s10815-025-03660-w","volume":"42","author":"R Zhou","year":"2025","unstructured":"Zhou R, Wei Y, Xiong Y, et al. Artificial intelligence in primary ovarian insufficiency management: opportunities and challenges. J Assist Reprod Genet. 2025;42(11):3581\u201394.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2083_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.fertnstert.2023.05.148","volume":"120","author":"E Hariton","year":"2023","unstructured":"Hariton E, Pavlovic Z, Fanton M, Jiang VS. Applications of artificial intelligence in ovarian stimulation: a tool for improving efficiency and outcomes. Fertil Steril. 2023;120(1):8\u201316.","journal-title":"Fertil Steril"},{"key":"2083_CR10","doi-asserted-by":"publisher","first-page":"1581157","DOI":"10.3389\/fonc.2025.1581157","volume":"15","author":"C Tang","year":"2025","unstructured":"Tang C, Xu Z, Duan H, Zhang S. Advancements in artificial intelligence for ultrasound diagnosis of ovarian cancer: a comprehensive review. Front Oncol. 2025;15:1581157.","journal-title":"Front Oncol"},{"issue":"2","key":"2083_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/cancers16020422","volume":"16","author":"S Mitchell","year":"2024","unstructured":"Mitchell S, Nikolopoulos M, El-Zarka A, et al. Artificial Intelligence in Ultrasound Diagnoses of Ovarian Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2024;16(2):422.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2083_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41698-023-00432-6","volume":"7","author":"J Breen","year":"2023","unstructured":"Breen J, Allen K, Zucker K, et al. Artificial intelligence in ovarian cancer histopathology: a systematic review. NPJ Precis Oncol. 2023;7(1):83.","journal-title":"NPJ Precis Oncol"},{"key":"2083_CR13","doi-asserted-by":"publisher","first-page":"e53396","DOI":"10.2196\/53396","volume":"26","author":"R AlSaad","year":"2024","unstructured":"AlSaad R, Abd-Alrazaq A, Choucair F, et al. Harnessing Artificial Intelligence to Predict Ovarian Stimulation Outcomes in In Vitro Fertilization: Scoping Review. J Med Internet Res. 2024;26:e53396.","journal-title":"J Med Internet Res"},{"key":"2083_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"3","key":"2083_CR15","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2589-7500(23)00245-5","volume":"6","author":"G Cai","year":"2024","unstructured":"Cai G, Huang F, Gao Y, et al. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study. Lancet Digit Health. 2024;6(3):e176\u201386.","journal-title":"Lancet Digit Health"},{"issue":"6","key":"2083_CR16","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.acra.2024.04.032","volume":"31","author":"A Eresen","year":"2024","unstructured":"Eresen A. Leveraging Artificial Intelligence to Revolutionize Ovarian Cancer Diagnosis. Acad Radiol. 2024;31(6):2402\u20134.","journal-title":"Acad Radiol"},{"issue":"9","key":"2083_CR17","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1111\/srt.70050","volume":"30","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang F, Zhu X, et al. Mechanism of Zuogui pill enhancing ovarian function and skin elastic repair in premature aging rats based on artificial intelligence medical image analysis. Skin Res Technol. 2024;30(9):e70050.","journal-title":"Skin Res Technol"},{"key":"2083_CR18","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2147\/OTT.S307546","volume":"14","author":"J Ma","year":"2021","unstructured":"Ma J, Yang J, Jin Y, et al. Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study. Onco Targets Ther. 2021;14:3267\u201380.","journal-title":"Onco Targets Ther"},{"key":"2083_CR19","doi-asserted-by":"publisher","first-page":"1649746","DOI":"10.3389\/frai.2025.1649746","volume":"8","author":"I Garcia-Atutxa","year":"2025","unstructured":"Garcia-Atutxa I, Villanueva-Flores F, Barrio ED, et al. Artificial intelligence for ovarian cancer diagnosis via ultrasound: a systematic review and quantitative assessment of model performance. Front Artif Intell. 2025;8:1649746.","journal-title":"Front Artif Intell"},{"issue":"3","key":"2083_CR20","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12020-024-04031-8","volume":"86","author":"T Gurbuz","year":"2024","unstructured":"Gurbuz T, Gokmen O, Devranoglu B, et al. Artificial intelligence in reproductive endocrinology: an in-depth longitudinal analysis of ChatGPTv4\u2019s month-by-month interpretation and adherence to clinical guidelines for diminished ovarian reserve. Endocrine. 2024;86(3):1171\u20137.","journal-title":"Endocrine"},{"issue":"3","key":"2083_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/cancers15030966","volume":"15","author":"A Laios","year":"2023","unstructured":"Laios A, Kalampokis E, Johnson R, et al. Development of a Novel Intra-Operative Score to Record Diseases\u2019 Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence. Cancers (Basel). 2023;15(3):966.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2083_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/JU.0000000000004435","volume":"213","author":"EV Li","year":"2025","unstructured":"Li EV, Ren Y, Griffin J, et al. An Artificial Intelligence-Digital Pathology Algorithm Predicts Survival After Radical Prostatectomy From the Prostate, Lung, Colorectal, and Ovarian Cancer Trial. J Urol. 2025;213(5):600\u20138.","journal-title":"J Urol"},{"key":"2083_CR23","doi-asserted-by":"publisher","first-page":"724785","DOI":"10.3389\/fgene.2021.724785","volume":"12","author":"F Hamidi","year":"2021","unstructured":"Hamidi F, Gilani N, Belaghi RA, et al. Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence. Front Genet. 2021;12:724785.","journal-title":"Front Genet"},{"issue":"1","key":"2083_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00432-022-04468-2","volume":"149","author":"R Aghayousefi","year":"2023","unstructured":"Aghayousefi R, Hosseiniyan Khatibi SM, Zununi Vahed S, et al. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches. J Cancer Res Clin Oncol. 2023;149(1):325\u201341.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2083_CR25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/cancers15041058","volume":"15","author":"DA Binas","year":"2023","unstructured":"Binas DA, Tzanakakis P, Economopoulos TL, et al. A Novel Approach for Estimating Ovarian Cancer Tissue Heterogeneity through the Application of Image Processing Techniques and Artificial Intelligence. Cancers (Basel). 2023;15(4):1058.","journal-title":"Cancers (Basel)"},{"issue":"37","key":"2083_CR26","doi-asserted-by":"publisher","first-page":"11696","DOI":"10.1039\/D5TB00993F","volume":"13","author":"T Hu","year":"2025","unstructured":"Hu T, Xiao H, Ji S, et al. An artificial intelligence-enhanced early ovarian cancer diagnosis biosensor. J Mater Chem B. 2025;13(37):11696\u2013707.","journal-title":"J Mater Chem B"},{"issue":"1","key":"2083_CR27","doi-asserted-by":"publisher","first-page":"18625","DOI":"10.1038\/s41598-022-23149-1","volume":"12","author":"RO Bahado-Singh","year":"2022","unstructured":"Bahado-Singh RO, Ibrahim A, Al-Wahab Z, et al. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer. Sci Rep. 2022;12(1):18625.","journal-title":"Sci Rep"},{"key":"2083_CR28","doi-asserted-by":"publisher","first-page":"102439","DOI":"10.1016\/j.tranon.2025.102439","volume":"59","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wang K, Song Y, Li B. Enhancing ovarian cancer prognosis with an artificial intelligence-derived model: Multi-omics integration and therapeutic implications. Transl Oncol. 2025;59:102439.","journal-title":"Transl Oncol"},{"issue":"3","key":"2083_CR29","first-page":"e70138","volume":"8","author":"F Asadi","year":"2025","unstructured":"Asadi F, Rahimi M, Ramezanghorbani N, Almasi S. Comparing the Effectiveness of Artificial Intelligence Models in Predicting Ovarian Cancer Survival: A Systematic Review. Cancer Rep (Hoboken). 2025;8(3):e70138.","journal-title":"Cancer Rep (Hoboken)"},{"key":"2083_CR30","doi-asserted-by":"publisher","first-page":"1362588","DOI":"10.3389\/fmed.2024.1362588","volume":"11","author":"L Liu","year":"2024","unstructured":"Liu L, Cai W, Zhou C, et al. Ultrasound radiomics-based artificial intelligence model to assist in the differential diagnosis of ovarian endometrioma and ovarian dermoid cyst. Front Med (Lausanne). 2024;11:1362588.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"2083_CR31","first-page":"2261","volume":"10","author":"D Horesh","year":"2022","unstructured":"Horesh D, Kohavi S, Shilony-Nalaboff L, et al. Virtual Reality Combined with Artificial Intelligence (VR-AI) Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Healthc (Basel). 2022;10(11):2261.","journal-title":"Healthc (Basel)"},{"issue":"14","key":"2083_CR32","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/cancers14143447","volume":"14","author":"A Laios","year":"2022","unstructured":"Laios A, Kalampokis E, Johnson R, et al. Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer. Cancers (Basel). 2022;14(14):3447.","journal-title":"Cancers (Basel)"},{"key":"2083_CR33","doi-asserted-by":"publisher","first-page":"1200354","DOI":"10.3389\/fmolb.2023.1200354","volume":"10","author":"T Geng","year":"2023","unstructured":"Geng T, Zheng M, Wang Y, et al. An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma. Front Mol Biosci. 2023;10:1200354.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"2083_CR34","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-18-3378","volume":"25","author":"E Kawakami","year":"2019","unstructured":"Kawakami E, Tabata J, Yanaihara N, et al. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers. Clin Cancer Res. 2019;25(10):3006\u201315.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2083_CR35","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/biolre\/ioae048","volume":"110","author":"GM Blevins","year":"2024","unstructured":"Blevins GM, Flanagan CL, Kallakuri SS, et al. Quantification of follicles in human ovarian tissue using image processing software and trained artificial intelligence. Biol Reprod. 2024;110(6):1086\u201399.","journal-title":"Biol Reprod"},{"issue":"4","key":"2083_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/jpm12040607","volume":"12","author":"A Laios","year":"2022","unstructured":"Laios A, Kalampokis E, Johnson R, et al. Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer. J Pers Med. 2022;12(4):607.","journal-title":"J Pers Med"},{"issue":"12","key":"2083_CR37","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1245\/s10434-015-4475-6","volume":"22","author":"A Enshaei","year":"2015","unstructured":"Enshaei A, Robson CN, Edmondson RJ. Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer. Ann Surg Oncol. 2015;22(12):3970\u20135.","journal-title":"Ann Surg Oncol"},{"key":"2083_CR38","doi-asserted-by":"publisher","unstructured":"Jiang N, Xie H, Lin J, Wang Y, Yin Y. Diagnosis and nursing intervention of gynecological ovarian endometriosis with magnetic resonance imaging under artificial intelligence algorithm. Comput Intell Neurosci. 2022;2022:3123310. https:\/\/doi.org\/10.1155\/2022\/3123310. Published 2022 Jun 11.","DOI":"10.1155\/2022\/3123310"},{"issue":"3","key":"2083_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/cbdd.13672","volume":"96","author":"S Pawar","year":"2020","unstructured":"Pawar S, Liew TO, Stanam A, Lahiri C. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence. Chem Biol Drug Des. 2020;96(3):995\u2013995.","journal-title":"Chem Biol Drug Des"},{"issue":"17","key":"2083_CR40","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.3390\/diagnostics13172813","volume":"13","author":"L Escudero Sanchez","year":"2023","unstructured":"Escudero Sanchez L, Buddenkotte T, Al Sa\u2019d M, et al. Integrating Artificial Intelligence Tools in the Clinical Research Setting: The Ovarian Cancer Use Case. Diagnostics (Basel). 2023;13(17):2813.","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"2083_CR41","first-page":"555","volume":"20","author":"HA Farooqi","year":"2024","unstructured":"Farooqi HA, Nabi R, Hayder Z, Zahid T. Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies. Asia Pac J Clin Oncol. 2024;20(4):555\u20136.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"2083_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13048-022-00994-2","volume":"15","author":"Y Feng","year":"2022","unstructured":"Feng Y, Wang Z, Cui R, et al. Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes. J Ovarian Res. 2022;15(1):64.","journal-title":"J Ovarian Res"},{"key":"2083_CR43","doi-asserted-by":"publisher","first-page":"107327482311595","DOI":"10.1177\/10732748231159553","volume":"30","author":"G Parpinel","year":"2023","unstructured":"Parpinel G, Laudani ME, Piovano E, Zola P, Lecuru F. The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review. Cancer Control. 2023;30:10732748231159553.","journal-title":"Cancer Control"},{"issue":"10","key":"2083_CR44","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ajpath.2024.06.010","volume":"194","author":"A Ueda","year":"2024","unstructured":"Ueda A, Nakai H, Miyagawa C, et al. Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian Cancer. Am J Pathol. 2024;194(10):1913\u201323.","journal-title":"Am J Pathol"},{"issue":"7","key":"2083_CR45","doi-asserted-by":"publisher","first-page":"e2203","DOI":"10.1002\/hsr2.2203","volume":"7","author":"SM Ayyoubzadeh","year":"2024","unstructured":"Ayyoubzadeh SM, Ahmadi M, Yazdipour AB, Ghorbani-Bidkorpeh F, Ahmadi M. Prediction of ovarian cancer using artificial intelligence tools. Health Sci Rep. 2024;7(7):e2203.","journal-title":"Health Sci Rep"},{"key":"2083_CR46","doi-asserted-by":"publisher","first-page":"975703","DOI":"10.3389\/fonc.2022.975703","volume":"12","author":"M Wu","year":"2022","unstructured":"Wu M, Zhao Y, Dong X, et al. Artificial intelligence-based preoperative prediction system for diagnosis and prognosis in epithelial ovarian cancer: A multicenter study. Front Oncol. 2022;12:975703.","journal-title":"Front Oncol"},{"issue":"1","key":"2083_CR47","doi-asserted-by":"publisher","first-page":"e2024.00001","DOI":"10.4293\/JSLS.2024.00001","volume":"28","author":"R Sinha","year":"2024","unstructured":"Sinha R, Rallabandi H, Bana R et al. Ovarian Loss in Laparoscopic and Robotic Cystectomy Compared Using Artificial Intelligence Pathology. JSLS. 2024;28(1): e2024.00001.","journal-title":"JSLS"},{"issue":"3","key":"2083_CR48","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13167-024-00374-4","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yang J, Chen S, et al. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling. EPMA J. 2024;15(3):525\u201344.","journal-title":"EPMA J"},{"key":"2083_CR49","doi-asserted-by":"publisher","first-page":"105608","DOI":"10.1016\/j.compbiomed.2022.105608","volume":"146","author":"J Zhou","year":"2022","unstructured":"Zhou J, Cao W, Wang L, Pan Z, Fu Y. Application of artificial intelligence in the diagnosis and prognostic prediction of ovarian cancer. Comput Biol Med. 2022;146:105608.","journal-title":"Comput Biol Med"},{"key":"2083_CR50","doi-asserted-by":"publisher","first-page":"101662","DOI":"10.1016\/j.eclinm.2022.101662","volume":"53","author":"HL Xu","year":"2022","unstructured":"Xu HL, Gong TT, Liu FH, et al. Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis. EClinicalMedicine. 2022;53:101662.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"2083_CR51","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.21873\/anticanres.14482","volume":"40","author":"M Akazawa","year":"2020","unstructured":"Akazawa M, Hashimoto K. Artificial Intelligence in Ovarian Cancer Diagnosis. Anticancer Res. 2020;40(8):4795\u2013800.","journal-title":"Anticancer Res"},{"key":"2083_CR52","doi-asserted-by":"publisher","first-page":"1626286","DOI":"10.3389\/fonc.2025.1626286","volume":"15","author":"R Li","year":"2025","unstructured":"Li R, Lei J, Tang X, et al. Artificial intelligence based on ultrasound for initial diagnosis of malignant ovarian cancer: a systematic review and meta-analysis. Front Oncol. 2025;15:1626286.","journal-title":"Front Oncol"},{"issue":"2","key":"2083_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00432-025-06134-9","volume":"151","author":"S Xu","year":"2025","unstructured":"Xu S, Zhu C, Wu M, et al. Artificial intelligence algorithm for preoperative prediction of FIGO stage in ovarian cancer based on clinical features integrated 18F-FDG PET\/CT metabolic and radiomics features. J Cancer Res Clin Oncol. 2025;151(2):87.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2083_CR54","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.fertnstert.2025.07.013","volume":"124","author":"J Chervenak","year":"2025","unstructured":"Chervenak J, Murugappan G, Kim J, Minjarez D. Progestin-primed ovarian stimulation: what new evidence shows about the role for artificial intelligence in clinical decision making. Fertil Steril. 2025;124(4):651\u20132.","journal-title":"Fertil Steril"},{"issue":"6","key":"2083_CR55","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s10815-025-03471-z","volume":"42","author":"JA Ortiz","year":"2025","unstructured":"Ortiz JA, Lled\u00f3 B, Luque L, et al. Pharmacogenetic analysis using artificial intelligence (AI) to identify polymorphisms associated with sub-optimal ovarian response and hyper-response. J Assist Reprod Genet. 2025;42(6):1863\u201373.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2083_CR56","doi-asserted-by":"publisher","first-page":"41891","DOI":"10.1038\/s41598-025-25901-9","volume":"15","author":"Z Chekini","year":"2025","unstructured":"Chekini Z, Dehghani T, Khayami R, et al. Identification of novel biomarkers for epithelial ovarian cancer through machine learning and explainable artificial intelligence using in silico and in vitro analysis. Sci Rep. 2025;15(1):41891.","journal-title":"Sci Rep"},{"issue":"2","key":"2083_CR57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40477-025-00983-3","volume":"28","author":"D Donatello","year":"2025","unstructured":"Donatello D. An overview of the use of cutting-edge artificial intelligence (AI) modeling to produce synthetic medical data (SMD) in decentralized clinical machine learning (ML) for ovarian cancer(OC) and ovarian lymphoma(OL). J Ultrasound. 2025;28(2):483\u201392.","journal-title":"J Ultrasound"},{"issue":"1","key":"2083_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12893-025-02766-3","volume":"25","author":"S Noei Teymoordash","year":"2025","unstructured":"Noei Teymoordash S, Zendehdel H, Norouzi AR, Kashian M. Diagnostic accuracy of artificial intelligence algorithms to predict remove all macroscopic disease and survival rate after complete surgical cytoreduction in patients with ovarian cancer: a systematic review and meta-analysis. BMC Surg. 2025;25(1):27.","journal-title":"BMC Surg"},{"key":"2083_CR59","doi-asserted-by":"publisher","unstructured":"Arlova A, Yano Maher JC, Anvari H, et al. The utility of artificial intelligence and deep learning to automate and accelerate follicle counts in human ovarian tissue. Biol Reprod. 2026;114(2):662\u201372. https:\/\/doi.org\/10.1093\/biolre\/ioaf250.","DOI":"10.1093\/biolre\/ioaf250"},{"issue":"5","key":"2083_CR60","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.fertnstert.2020.06.006","volume":"114","author":"G Letterie","year":"2020","unstructured":"Letterie G, Mac Donald A. Artificial intelligence in in vitro fertilization: a computer decision support system for day-to-day management of ovarian stimulation during in vitro fertilization. Fertil Steril. 2020;114(5):1026\u201331.","journal-title":"Fertil Steril"},{"issue":"22","key":"2083_CR61","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.3390\/cancers15225386","volume":"15","author":"A Laios","year":"2023","unstructured":"Laios A, Kalampokis E, Mamalis ME, et al. Exploring the Potential Role of Upper Abdominal Peritonectomy in Advanced Ovarian Cancer Cytoreductive Surgery Using Explainable Artificial Intelligence. Cancers (Basel). 2023;15(22):5386.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2083_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s43046-025-00337-4","volume":"37","author":"S Aminimoghaddam","year":"2026","unstructured":"Aminimoghaddam S, Torshizi HM, Pourali R, Mohazzab A. Artificial intelligence-based machine learning models for preoperative diagnosis and staging of ovarian tumors. J Egypt Natl Canc Inst. 2026;37(1):82.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"12","key":"2083_CR63","doi-asserted-by":"publisher","first-page":"9088","DOI":"10.3390\/curroncol29120711","volume":"29","author":"A Laios","year":"2022","unstructured":"Laios A, De Freitas DLD, Saalmink G, et al. Stratification of Length of Stay Prediction following Surgical Cytoreduction in Advanced High-Grade Serous Ovarian Cancer Patients Using Artificial Intelligence; the Leeds L-AI-OS Score. Curr Oncol. 2022;29(12):9088\u2013104.","journal-title":"Curr Oncol"},{"issue":"5","key":"2083_CR64","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.3802\/jgo.2018.29.e66","volume":"29","author":"G Bogani","year":"2018","unstructured":"Bogani G, Rossetti D, Ditto A, et al. Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer. J Gynecol Oncol. 2018;29(5):e66.","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"2083_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/curroncol32020073","volume":"32","author":"E Ratcliffe","year":"2025","unstructured":"Ratcliffe E, Devlin C, Munot S, et al. Incidence and Predictors of Acute Kidney Injury Following Advanced Ovarian Cancer Cytoreduction at a Tertiary UK Centre: An Exploratory Analysis and Insights from Explainable Artificial Intelligence. Curr Oncol. 2025;32(2):73.","journal-title":"Curr Oncol"},{"key":"2083_CR66","doi-asserted-by":"publisher","unstructured":"Hramyka A, Kelsey TW, Hanassab S, et al. Modelling follicular growth during ovarian stimulation using agent-based artificial intelligence. J Clin Endocrinol Metab. 2026;111(3):615\u201321. https:\/\/doi.org\/10.1210\/clinem\/dgaf539.","DOI":"10.1210\/clinem\/dgaf539"},{"issue":"11","key":"2083_CR67","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1007\/s00261-025-04977-x","volume":"50","author":"X Cai","year":"2025","unstructured":"Cai X, Han J, Zhou W, et al. The utility of low-dose pre-operative CT of ovarian tumor with artificial intelligence iterative reconstruction for diagnosing peritoneal invasion, lymph node and hepatic metastasis. Abdom Radiol (NY). 2025;50(11):5463\u201373.","journal-title":"Abdom Radiol (NY)"},{"key":"2083_CR68","doi-asserted-by":"publisher","unstructured":"Singh M, Betgeri SN, Kakar SS. Artificial intelligence (AI) and machine learning (ML) in ovarian cancer: transforming detection, treatment, and prevention. J Ovarian Res. 2026;19(1):91. https:\/\/doi.org\/10.1186\/s13048-026-01979-1. Published 28 Jan 2026.","DOI":"10.1186\/s13048-026-01979-1"},{"issue":"1","key":"2083_CR69","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/MS9.0000000000004340","volume":"88","author":"M Khizar","year":"2025","unstructured":"Khizar M, Zaib M, Babar M, Karimi H, Aminpoor H. Artificial intelligence in cancer genomics: refining diagnosis of hereditary breast and ovarian cancer syndromes. Ann Med Surg (Lond). 2025;88(1):999\u20131000.","journal-title":"Ann Med Surg (Lond)"},{"issue":"11","key":"2083_CR70","first-page":"1487","volume":"14","author":"H Ucuzal","year":"2025","unstructured":"Ucuzal H, K\u0131vrak M. Explainable Artificial Intelligence for Ovarian Cancer: Biomarker Contributions in Ensemble Models. Biology (Basel). 2025;14(11):1487.","journal-title":"Biology (Basel)"},{"issue":"3","key":"2083_CR71","doi-asserted-by":"publisher","first-page":"102903","DOI":"10.1016\/j.jogoh.2024.102903","volume":"54","author":"DB Olawade","year":"2025","unstructured":"Olawade DB, Teke J, Adeleye KK, et al. Artificial intelligence in in-vitro fertilization (IVF): A new era of precision and personalization in fertility treatments. J Gynecol Obstet Hum Reprod. 2025;54(3):102903.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"9","key":"2083_CR72","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/cancers12092373","volume":"12","author":"K Tanabe","year":"2020","unstructured":"Tanabe K, Ikeda M, Hayashi M, et al. Comprehensive Serum Glycopeptide Spectra Analysis Combined with Artificial Intelligence (CSGSA-AI) to Diagnose Early-Stage Ovarian Cancer. Cancers (Basel). 2020;12(9):2373.","journal-title":"Cancers (Basel)"},{"key":"2083_CR73","doi-asserted-by":"publisher","first-page":"587496","DOI":"10.3389\/fmed.2021.587496","volume":"8","author":"T He","year":"2021","unstructured":"He T, Huang L, Li J, Wang P, Zhang Z. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System. Front Med (Lausanne). 2021;8:587496.","journal-title":"Front Med (Lausanne)"},{"key":"2083_CR74","doi-asserted-by":"publisher","first-page":"1562558","DOI":"10.3389\/fmed.2025.1562558","volume":"12","author":"S Yasar","year":"2025","unstructured":"Yasar S, Melekoglu R. Proteomic alterations in ovarian cancer-Predicting residual disease status using artificial intelligence and SHAP-based biomarker interpretation. Front Med (Lausanne). 2025;12:1562558.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2083_CR75","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ygyno.2021.05.004","volume":"162","author":"SI Kim","year":"2021","unstructured":"Kim SI, Yoon S, Kim TM, et al. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique. Gynecol Oncol. 2021;162(1):72\u20139.","journal-title":"Gynecol Oncol"},{"key":"2083_CR76","doi-asserted-by":"publisher","first-page":"1713629","DOI":"10.3389\/fmed.2025.1713629","volume":"12","author":"Q Liu","year":"2026","unstructured":"Liu Q, Zhang C, Li P, et al. Artificial intelligence for precision management of epithelial ovarian cancer: a comprehensive review. Front Med (Lausanne). 2026;12:1713629.","journal-title":"Front Med (Lausanne)"},{"key":"2083_CR77","doi-asserted-by":"publisher","first-page":"105126","DOI":"10.1016\/j.critrevonc.2026.105126","volume":"219","author":"B G\u00fclmez","year":"2026","unstructured":"G\u00fclmez B. Artificial intelligence applications in ovarian cancer detection: A systematic literature review of deep learning approaches and clinical translation challenges. Crit Rev Oncol Hematol. 2026;219:105126.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2083_CR78","first-page":"140","volume":"6","author":"CJ Bixby","year":"2025","unstructured":"Bixby CJ, Miller B. Real-world use of an artificial intelligence-powered clinical decision support tool for ovarian stimulation. F S Rep. 2025;6(2):140\u20136.","journal-title":"F S Rep"},{"issue":"1","key":"2083_CR79","doi-asserted-by":"publisher","first-page":"14437","DOI":"10.1038\/s41598-025-98434-w","volume":"15","author":"X Ma","year":"2025","unstructured":"Ma X, Hsu YC, Asare A, et al. A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy. Sci Rep. 2025;15(1):14437.","journal-title":"Sci Rep"},{"key":"2083_CR80","doi-asserted-by":"publisher","unstructured":"Ord\u00e1s P, Crossa J, Chiva L. Artificial intelligence for single-omics in ovarian cancer: a methodological review. Int J Gynecol Cancer. https:\/\/doi.org\/10.1016\/j.ijgc.2025.104452. Published online 9\u00a0January 2026.","DOI":"10.1016\/j.ijgc.2025.104452"},{"key":"2083_CR81","doi-asserted-by":"publisher","unstructured":"Wygocki P, Zapa\u0142a A, Ulfig M, et al. An artificial intelligence platform for automated measurement and count estimation of ovarian follicles during ovarian stimulation and IVF: a multicenter study. J Assist Reprod Genet. 2026;43(3):715\u201329. https:\/\/doi.org\/10.1007\/s10815-025-03777-y.","DOI":"10.1007\/s10815-025-03777-y"},{"issue":"3","key":"2083_CR82","first-page":"406","volume":"6","author":"R Ojha","year":"2025","unstructured":"Ojha R. Commentary on Real-world use of an artificial intelligence-powered clinical decision support tool for ovarian stimulation. F S Rep. 2025;6(3):406.","journal-title":"F S Rep"},{"issue":"4","key":"2083_CR83","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1093\/ejendo\/lvaf062","volume":"192","author":"E Vale-Fernandes","year":"2025","unstructured":"Vale-Fernandes E, Pignatelli D, Monteiro MP. Should anti-M\u00fcllerian hormone be a diagnosis criterion for polycystic ovary syndrome? An in-depth review of pros and cons. Eur J Endocrinol. 2025;192(4):R29\u201343.","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02083-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02083-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02083-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:12:01Z","timestamp":1782864721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02083-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02083-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}